Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B. (Q37327103)

19 August 2017

1 reference

title

Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B. (English)

1 reference

invasive fungal infections

19 August 2017

1 reference

1 reference

Amparo Solé

1

1 reference

19 August 2017

publication date

1 November 2008

1 reference

International Journal of Antimicrobial Agents

19 August 2017

published in

1 reference

19 August 2017

volume

32 Suppl 2

1 reference

19 August 2017

page(s)

S161-5

1 reference

Pulmonary complications of solid organ and hematopoietic stem cell transplantation

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

The changing face of fungal infections in health care settings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Fungal infections in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Aspergillus infections in lung transplant recipients: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Antifungal prophylaxis in transplant recipients: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Variation in antifungal prophylaxis strategies in lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Aerosolised antibiotics: a critical appraisal of their use.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Invasive aspergillosis in the recipients of liver retransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Late-onset invasive aspergillosis in organ transplant recipients in the current era.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

A review of critical periods for opportunistic infection in the new transplantation era.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970019-0

7 January 2021

10.1016/S0924-8579(08)70019-0

Identifiers

DOI

1 reference

19 August 2017

1 reference